Popular Stories
- Arcutis Biotherapeutics (N
- Nexgel: Bringing Innovatio
- Ekso Bionics: Advancing Ra
- Esperion: Revolutionizing
- AMSC: Restructuring the Po
- Harrow Inc: Envisioning a
SAMPLE REPORTS
- Company Summary.pdf
- Daily Market Updates.pdf
- Initiating Coverage.pdf
- Investors' Presentation.pdf
- Portfolio Performance Analysis.pdf
- Pre-Result Analysis.pdf
- Result Review.pdf
- Short Initiating Coverage.pdf

Roflumilast brand name Tag

  • All
  • Beauty
  • Biotechnology
  • Cannabis
  • Communications
  • Education
  • Energy
  • Entertainment
  • Environment
  • ETFs
  • Finance
  • Fitness
  • Food and Beverage
  • Healthcare
  • Hospitality
  • Insider Trading
  • Investing Ideas
  • Macro
  • Market Insight
  • Miscellaneous
  • Power
  • Real Estate
  • Retail
  • Sectors
  • Security
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Arcutis Biotherapeutics (NASDAQ: ARQT): Time to Have Skin in This Game!

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a commercial-stage company creating a portfolio of targeted therapies to treat immune-mediated dermatological diseases and conditions.   Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) Market Cap: $2.47B; Current Share Price: 20.57 USD Data by YCharts ZORYVE® - Time to Have Skin in This Game!   The Company has...

08 October, 2025 0 Comments
Key Catalysts Make Arcutis a Must Watch!
Key Catalysts Make Arcutis a Must Watch!

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a biopharmaceutical company developing novel treatments for dermatological diseases, announced the acceptance of the New Drug Submission (NDS) for roflumilast cream 0.3% (ARQ-151) for the treatment of plaque psoriasis in adults and adolescents, filed by Arcutis Canada Inc., a subsidiary of...

25 July, 2022 0 Comments
WordPress Video Lightbox Plugin